Segment Information (Tabulation of Business Segment Information Based on Current Segmentation) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting Information [Line Items]
Total Consolidated Revenue	$ 412,658	$ 369,082	$ 1,174,745	$ 1,086,185
Total consolidated adjusted operating income	89,782	72,968	228,660	217,640
Restructuring expense	(473)	(1,278)	(1,217)	(17,706)
Business integration expense	(18,450)	(11,346)	(30,621)	(35,702)
Litigation reserve	0	0	(18,500)	0
Loss on assets held for sale	0	0	(647)	0
Debt modification costs	(848)	0	(848)	0
Gain on sale of assets	0	13,317	0	13,317
Total consolidated operating income	61,725	59,429	148,531	128,613
Interest expense	(16,560)	(14,457)	(48,910)	(47,806)
Other income, net	2,871	3,980	8,648	3,301
Total consolidated income from continuing operations before income taxes	48,036	48,952	108,269	84,108
Total Consolidated capital expenditures	21,686	9,309	52,014	19,056
Total consolidated depreciation expense	11,392	10,157	32,106	31,618
Total consolidated intangible amortization expense	(8,286)	(14,232)	(28,296)	(48,936)
Chamberlain
Segment Reporting Information [Line Items]
Total Consolidated Revenue	170,338	149,737	466,487	426,538
Walden University
Segment Reporting Information [Line Items]
Total Consolidated Revenue	150,607	132,874	439,023	395,715
Medical and Veterinary
Segment Reporting Information [Line Items]
Total Consolidated Revenue	91,713	86,471	269,235	263,932
Operating Segments [Member] | Chamberlain
Segment Reporting Information [Line Items]
Total Consolidated Revenue	170,338	149,737	466,487	426,538
Total consolidated adjusted operating income	43,349	39,589	97,313	99,820
Total Consolidated capital expenditures	9,811	4,002	20,853	6,920
Total consolidated depreciation expense	5,312	4,405	14,790	12,985
Operating Segments [Member] | Walden University
Segment Reporting Information [Line Items]
Total Consolidated Revenue	150,607	132,874	439,023	395,715
Total consolidated adjusted operating income	31,871	24,628	93,141	78,181
Total Consolidated capital expenditures	5,311	1,198	10,872	2,291
Total consolidated depreciation expense	2,214	2,439	6,681	7,303
Total consolidated intangible amortization expense	(8,286)	(14,232)	(28,296)	(48,936)
Operating Segments [Member] | Medical and Veterinary
Segment Reporting Information [Line Items]
Total Consolidated Revenue	91,713	86,471	269,235	263,932
Total consolidated adjusted operating income	22,953	16,893	59,521	56,506
Restructuring expense	(194)	(421)	(379)	(7,334)
Total Consolidated capital expenditures	3,648	1,277	6,928	2,192
Total consolidated depreciation expense	3,174	3,231	9,228	9,367
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Total consolidated adjusted operating income	(8,391)	(8,142)	(21,315)	(16,867)
Total Consolidated capital expenditures	2,916	2,832	13,361	7,653
Total consolidated depreciation expense	$ 692	$ 82	$ 1,407	$ 1,963